Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Severe COVID-19
NCT05596617Completed
- Sponsor
- Hospital Clínico San Carlos
- Start
- Apr 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of melatonin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoints: Severe adverse events, Sequential Organ Failure Assessment at Day 30 and 1 more. Started Apr 2020; status: completed.
02
Drugs
melatonin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05596617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05596617.